In addition, exploiting the mechanism by which NLRP6 suppresses gastric tumorigenesis via P14ARF–Mdm2–P53-dependent cellular senescence may also prove to be a promising strategy for gastric cancer therapy. The gene discussed is NLRP6; the disease is gastric cancer.